vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and RAYONIER INC (RYN). Click either name above to swap in a different company.

RAYONIER INC is the larger business by last-quarter revenue ($276.8M vs $205.4M, roughly 1.3× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -4.5%, a 12.7% gap on every dollar of revenue. On growth, RAYONIER INC posted the faster year-over-year revenue change (233.9% vs 12.9%). Over the past eight quarters, RAYONIER INC's revenue compounded faster (66.7% CAGR vs 19.1%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

Rayonier Inc., headquartered in Wildlight, Florida is a timberland real estate investment trust ("REIT") with assets located in softwood timber growing regions in the United States and New Zealand. Its core business segments are timber and real estate.

COLL vs RYN — Head-to-Head

Bigger by revenue
RYN
RYN
1.3× larger
RYN
$276.8M
$205.4M
COLL
Growing faster (revenue YoY)
RYN
RYN
+221.0% gap
RYN
233.9%
12.9%
COLL
Higher net margin
COLL
COLL
12.7% more per $
COLL
8.3%
-4.5%
RYN
Faster 2-yr revenue CAGR
RYN
RYN
Annualised
RYN
66.7%
19.1%
COLL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
COLL
COLL
RYN
RYN
Revenue
$205.4M
$276.8M
Net Profit
$17.0M
$-12.4M
Gross Margin
62.5%
100.0%
Operating Margin
29.6%
Net Margin
8.3%
-4.5%
Revenue YoY
12.9%
233.9%
Net Profit YoY
35.3%
-264.7%
EPS (diluted)
$0.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
RYN
RYN
Q1 26
$276.8M
Q4 25
$205.4M
$117.5M
Q3 25
$209.4M
$177.5M
Q2 25
$188.0M
$106.5M
Q1 25
$177.8M
$82.9M
Q4 24
$181.9M
$650.5M
Q3 24
$159.3M
$124.1M
Q2 24
$145.3M
$99.6M
Net Profit
COLL
COLL
RYN
RYN
Q1 26
$-12.4M
Q4 25
$17.0M
$25.9M
Q3 25
$31.5M
$43.2M
Q2 25
$12.0M
$408.7M
Q1 25
$2.4M
$-3.4M
Q4 24
$12.5M
$327.1M
Q3 24
$9.3M
$28.8M
Q2 24
$19.6M
$1.9M
Gross Margin
COLL
COLL
RYN
RYN
Q1 26
100.0%
Q4 25
62.5%
41.9%
Q3 25
61.7%
32.9%
Q2 25
57.7%
29.7%
Q1 25
54.8%
21.7%
Q4 24
54.0%
53.8%
Q3 24
60.8%
30.4%
Q2 24
62.5%
25.4%
Operating Margin
COLL
COLL
RYN
RYN
Q1 26
Q4 25
29.6%
23.0%
Q3 25
29.7%
23.5%
Q2 25
18.7%
13.7%
Q1 25
12.2%
0.1%
Q4 24
20.9%
47.7%
Q3 24
21.9%
15.2%
Q2 24
32.7%
4.6%
Net Margin
COLL
COLL
RYN
RYN
Q1 26
-4.5%
Q4 25
8.3%
22.1%
Q3 25
15.0%
24.3%
Q2 25
6.4%
383.6%
Q1 25
1.4%
-4.1%
Q4 24
6.9%
45.1%
Q3 24
5.9%
23.2%
Q2 24
13.5%
1.9%
EPS (diluted)
COLL
COLL
RYN
RYN
Q1 26
Q4 25
$0.48
$0.14
Q3 25
$0.84
$0.28
Q2 25
$0.34
$2.63
Q1 25
$0.07
$-0.02
Q4 24
$0.36
$2.18
Q3 24
$0.27
$0.19
Q2 24
$0.52
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
RYN
RYN
Cash + ST InvestmentsLiquidity on hand
$386.7M
$681.7M
Total DebtLower is stronger
$2.1B
Stockholders' EquityBook value
$301.7M
$5.3B
Total Assets
$1.7B
$7.7B
Debt / EquityLower = less leverage
0.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
RYN
RYN
Q1 26
$681.7M
Q4 25
$386.7M
$842.9M
Q3 25
$285.9M
$919.6M
Q2 25
$222.2M
$892.3M
Q1 25
$197.8M
$216.2M
Q4 24
$162.8M
$303.1M
Q3 24
$120.0M
$51.9M
Q2 24
$271.6M
$120.2M
Total Debt
COLL
COLL
RYN
RYN
Q1 26
$2.1B
Q4 25
$845.3M
Q3 25
$845.1M
Q2 25
$844.9M
Q1 25
$1.0B
Q4 24
$1.0B
Q3 24
$1.3B
Q2 24
$1.4B
Stockholders' Equity
COLL
COLL
RYN
RYN
Q1 26
$5.3B
Q4 25
$301.7M
$2.2B
Q3 25
$274.8M
$2.3B
Q2 25
$232.2M
$2.3B
Q1 25
$234.4M
$1.9B
Q4 24
$228.8M
$1.8B
Q3 24
$234.3M
$1.8B
Q2 24
$216.6M
$1.8B
Total Assets
COLL
COLL
RYN
RYN
Q1 26
$7.7B
Q4 25
$1.7B
$3.4B
Q3 25
$1.6B
$3.5B
Q2 25
$1.6B
$3.5B
Q1 25
$1.6B
$3.4B
Q4 24
$1.7B
$3.5B
Q3 24
$1.6B
$3.5B
Q2 24
$1.1B
$3.5B
Debt / Equity
COLL
COLL
RYN
RYN
Q1 26
0.39×
Q4 25
0.38×
Q3 25
0.37×
Q2 25
0.37×
Q1 25
0.55×
Q4 24
0.59×
Q3 24
0.72×
Q2 24
0.75×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
RYN
RYN
Operating Cash FlowLast quarter
$123.0M
Free Cash FlowOCF − Capex
$122.4M
FCF MarginFCF / Revenue
59.6%
Capex IntensityCapex / Revenue
0.3%
7.4%
Cash ConversionOCF / Net Profit
7.25×
TTM Free Cash FlowTrailing 4 quarters
$327.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
RYN
RYN
Q1 26
Q4 25
$123.0M
$256.7M
Q3 25
$78.4M
$116.2M
Q2 25
$72.4M
$61.0M
Q1 25
$55.4M
$27.7M
Q4 24
$84.6M
$261.6M
Q3 24
$-9.0M
$66.2M
Q2 24
$67.4M
$55.3M
Free Cash Flow
COLL
COLL
RYN
RYN
Q1 26
Q4 25
$122.4M
Q3 25
$78.3M
$99.9M
Q2 25
$72.4M
Q1 25
$54.6M
Q4 24
$84.1M
Q3 24
$-9.2M
$42.2M
Q2 24
$67.1M
FCF Margin
COLL
COLL
RYN
RYN
Q1 26
Q4 25
59.6%
Q3 25
37.4%
56.3%
Q2 25
38.5%
Q1 25
30.7%
Q4 24
46.2%
Q3 24
-5.8%
34.0%
Q2 24
46.2%
Capex Intensity
COLL
COLL
RYN
RYN
Q1 26
7.4%
Q4 25
0.3%
Q3 25
0.1%
9.2%
Q2 25
0.0%
Q1 25
0.4%
Q4 24
0.3%
Q3 24
0.2%
19.3%
Q2 24
0.2%
Cash Conversion
COLL
COLL
RYN
RYN
Q1 26
Q4 25
7.25×
9.91×
Q3 25
2.49×
2.69×
Q2 25
6.05×
0.15×
Q1 25
22.92×
Q4 24
6.75×
0.80×
Q3 24
-0.96×
2.30×
Q2 24
3.44×
29.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLL
COLL

Segment breakdown not available.

RYN
RYN

Wood Products$108.5M39%
Southern Timber$88.7M32%
Real Estate$59.8M22%
Northwest Timber$32.1M12%

Related Comparisons